# Exer Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/exer-labs

- Industry: Software
- Headquarters: Denver, US
- Website: www.exer.ai
- Total disclosed funding: $4.5M
- Latest round: Seed (Oct 7, 2020)
- Investors on record: 7

## About

Exer Labs, Inc. leverages innovative Clinical AI technology to enhance patient care specifically for musculoskeletal and motion disorders, providing actionable insights to healthcare providers.Founded in 2019, Exer Labs, Inc. is headquartered in Denver, US, and focuses on developing Clinical AI solutions. The company has secured USD 2.000 mn in funding, primarily through a Seed round in October 2020, with investments from AME Cloud Ventures, Granite Asia, Morado Ventures, Range Ventures, Service Provider Capital, Shatter Fund, and Signia Ventures. The founders are Clint Gehde, Sean Cook, and Zaw Thet, with Zaw Thet serving as the CEO. Exer Labs has completed a total of 2 deals since its inception, enhancing its operational strategy with a focus on advanced healthcare technology.Exer AI specializes in delivering advanced Clinical AI solutions aimed at improving patient care for musculoskeletal (MSK) and motion disorders. Their core offering is a Clinical AI platform that transforms real-time motion data into actionable insights. This system enables healthcare providers to enhance clinical decision-making by offering personalized treatment plans, facilitating early detection of potential patient changes, and ultimately improving recovery outcomes. The platform functions without the need for wearables or sensors, allowing clinicians to gather objective motion assessments from various settings, including in-clinic visits, telehealth consultations, and at-home evaluations. Exer AI serves a diverse clientele, including orthopedic clinics, senior care facilities, neurology departments, and primary care practices, enhancing their services across North America and select regions in Europe.Exer AI generates revenue through a subscription-based model, offering their Clinical AI platform to healthcare providers and institutions. The transaction structure typically involves direct contracts with clinics and hospitals, where providers subscribe to access the platform's features, including real-time motion analytics and clinical decision support tools. Pricing plans are tailored to meet the specific needs of organizations, with various tiers designed to accommodate different scales of operation and patient volumes. The company's offerings are positioned to appeal to a broad range of healthcare providers, from small practices to large healthcare systems, ensuring they can integrate Exer AI’s capabilities into their existing workflows smoothly. Flagship services focus on enhancing treatment strategies for orthopedic conditions, particularly in the assessment and management of hand and wrist disorders.Exer Labs plans to utilize the recent funding of USD 2.000 mn raised in October 2020 to bolster its product development and market expansion strategies. The company is designing new features for its Clinical AI platform aimed at improving user experience and clinical outcomes, with anticipated releases slated for early 2023. Additionally, Exer Labs is targeting expansion in the European healthcare market, aiming to establish partnerships with new clinics and hospitals by late 2023, thereby enhancing its service footprint.

## Funding rounds

- Seed, Oct 7, 2020, $2M — Granite Asia, Morado Ventures, Signia Ventures, AME Cloud Ventures, Service Provider Capital, Shatter Fund, Range Ventures
- Seed, May 29, 2019, $2.5M — Signia Ventures

## Investors

- Signia Ventures (https://capitalatlas.ai/funds/signia-ventures) — Seed
- Granite Asia (https://capitalatlas.ai/funds/granite-asia) — Seed
- Morado Ventures (https://capitalatlas.ai/funds/morado-ventures) — Seed
- AME Cloud Ventures (https://capitalatlas.ai/funds/ame-cloud-ventures) — Seed
- Service Provider Capital (https://capitalatlas.ai/funds/service-provider-capital) — Seed
- Shatter Fund (https://capitalatlas.ai/funds/shatter-fund) — Seed
- Range Ventures (https://capitalatlas.ai/funds/range-ventures) — Seed
